Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Epilepsies of early childhood are frequently resistant to therapy and often associated with cognitive and behavioural comorbidity. Aetiology focused precision medicine, notably gene-based therapies, may prevent seizures and comorbidities. Epidemiological data utilizing modern diagnostic techniques including whole genome sequencing and neuroimaging can inform diagnostic strategies and therapeutic trials. We present a 3-year, multicentre prospective cohort study, involving all children under 3 years of age in Scotland presenting with epilepsies. We used two independent sources for case identification: clinical reporting and EEG record review. Capture-recapture methodology was then used to improve the accuracy of incidence estimates. Socio-demographic and clinical details were obtained at presentation, and 24 months later. Children were extensively investigated for aetiology. Whole genome sequencing was offered for all patients with drug-resistant epilepsy for whom no aetiology could yet be identified. Multivariate logistic regression modelling was used to determine associations between clinical features, aetiology, and outcome. Three hundred and ninety children were recruited over 3 years. The adjusted incidence of epilepsies presenting in the first 3 years of life was 239 per 100 000 live births [95% confidence interval (CI) 216–263]. There was a socio-economic gradient to incidence, with a significantly higher incidence in the most deprived quintile (301 per 100 000 live births, 95% CI 251–357) compared with the least deprived quintile (182 per 100 000 live births, 95% CI 139–233), χ2 odds ratio = 1.7 (95% CI 1.3–2.2). The relationship between deprivation and incidence was only observed in the group without identified aetiology, suggesting that populations living in higher deprivation areas have greater multifactorial risk for epilepsy. Aetiology was determined in 54% of children, and epilepsy syndrome was classified in 54%. Thirty-one per cent had an identified genetic cause for their epilepsy. We present novel data on the aetiological spectrum of the most commonly presenting epilepsies of early childhood. Twenty-four months after presentation, 36% of children had drug-resistant epilepsy (DRE), and 49% had global developmental delay (GDD). Identification of an aetiology was the strongest determinant of both DRE and GDD. Aetiology was determined in 82% of those with DRE, and 75% of those with GDD. In young children with epilepsy, genetic testing should be prioritized as it has the highest yield of any investigation and is most likely to inform precision therapy and prognosis. Epilepsies in early childhood are 30% more common than previously reported. Epilepsies of undetermined aetiology present more frequently in deprived communities. This likely reflects increased multifactorial risk within these populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common DEE syndrome is Infantile Epileptic Spasms Syndrome (IESS) with an incidence of 30.7 in 100,000 individuals (95% CI 22.9-40.2) to 48.9 in 100,000 individuals (95% CI 37.0-64.7);~27% of IESS have a structural aetiology 3,9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Incidence estimates have been reported for many DEE syndromes; however, around one-third of patients cannot be classified as having a specific syndrome 3,9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“In comparison, the estimated incidence of all epilepsies presenting under 3 years was 239 in 100,000 (95% CI 216-263) in a prospective study in Scotland, UK, with DEEs accounting for 86.1 in 100,000 (95% CI 72.7-101.3)children 9 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ILAE official report: a practical clinical definition of epilepsy
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., et al. (2014) · Epilepsia · doi:10.1111/epi.12550 · Cited by 6,108
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054
Self-citationKwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02397.x · Cited by 4,877
Fisher, R. S., Boas, W. V. E., Blume, W., Elger, C., Genton, P., Lee, P., & Engel, J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.66104.x · Cited by 3,671
Beghi, E., Berg, A., Carpio, A., Forsgren, L., Hesdorffer, D. C., Hauser, W. A., Malmgren, K., Shinnar, S., Temkin, N., Thurman, D., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00273_1.x · Cited by 2,296
Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02586.x · Cited by 2,073 · cited 1×
“On a population level, the highest age-specific incidences of 460 per 100 000 are observed in children under 5 years of age and in adults over 65 years of age.(9) A significant proportion (35%) of children presenting with epilepsies in the first 3 years of life develop drugresistant seizures.”
BackgroundTrial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711 · cited 1×
“Precise clinical classification of epilepsy syndrome, and identification of a genetic aetiology, helps guide therapeutic strategy, exemplified by randomized controlled trials in Lennox-Gastaut syndrome,(4,5) and Dravet syndrome.(6,7) For the individually rare but severe epilepsies caused by large effect mutations in a…”
BackgroundEffect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., Greenwood, S. M., Roberts, C., Checketts, D., VanLandingham, K. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714631 · Cited by 1,015
Self-citationThiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30136-3 · Cited by 905
Self-citationState of the Art Review: Poverty and the Developing Brain
Johnson, S. B., Riis, J. L., & Noble, K. G. (2016) · Pediatrics · doi:10.1542/peds.2015-3075 · Cited by 624
Cited by
Items 201–300 of 308
Alamad, B., Elliott, K., & Knight, J. C. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.25.pr5
Knight, J. C. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.25.pr1
Self-citationAlamad, B., Elliott, K., & Knight, J. C. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.25.pr8
Knight, J. C. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.25.pr6
Self-citationAlamad, B., Elliott, K., & Knight, J. C. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.25.pr9
Alamad, B., Elliott, K., & Knight, J. C. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.25.pr3
Alamad, B., Elliott, K., & Knight, J. C. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.25.pr2
Alamad, B., Elliott, K., & Knight, J. C. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.25.pr7
Alamad, B., Elliott, K., & Knight, J. C. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.25.pr4
Kumandaş & Canpolat Pediatrik ve Neonatal EEG Atlası
Çalık, M., Yilmaz, Y., Işıkay, S., Al-Haıthamy, S., Kırık, S., Günbey, C., Yarar, Ç., Hancı, F., Akbaş, S., Arhan, E., et al. (2023) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2036
Prostaglandin E2 as neuroinflammatory target in childhood resistant epilepsies
Gakharia, T., Bakhtadze, S., Khachapuridze, N., & Kapanadze, N. (2024) · GEORGIAN SCIENTISTS · doi:10.52340/gs.2024.06.01.35
Evaluation of Serum Endocan Level and Erectile Functions in Patients with Psoriasis
Elesawy, F. M., AbdelKhalik, G., El-Ghaffar, A. O. A., & shalaby, S. (2024) · Benha Journal of Applied Sciences · doi:10.21608/bjas.2024.274770.1348
“Disagreements in study methodology on age and socioeconomic level likely account for the large variation in these variables [23].”
BackgroundGupta, C., Narang, B., Thernal, S. J., Sharma, R., Chatterjee, S., Ramprasad, V., Murugan, S., Goyal, P., Bansal, R. K., & Jain, V. (2024) · Research Square · doi:10.21203/rs.3.rs-4390174/v1
Advances in Self-Limited Infantile Epilepsy
冯, 欣. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451689
Gupta, C., Narang, B., Thernal, S. J., Sharma, R., Chatterjee, S., Ramprasad, V., Murugan, S., Goyal, P., Bansal, R. K., & Jain, V. (2024) · Research Square · doi:10.21203/rs.3.rs-4390174/v2
Effectiveness and Safety of Lacosamide in Managing Pediatric Individuals with Focal Seizures
Fu, Z., Sun, D., Xia, C., Tang, Z., Li, X., Wang, H., Cui, J., & Zhang, Z. (2024) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.spl.939
The Spectrum of Self-Limited Infantile Epilepsy Syndromes
Saadeldin, I. Y., Matlik, H. N., Mohammed, H., Abdelmagid, T. A. M., & Babikir, H. E. H. (2024) · Journal of Pediatric Epilepsy · doi:10.1055/s-0044-1790254
Canpolat, Temel Pediatrik Epilepsi
Güzin, Y., Ünalp, A., Öztürk, S. B., Ayanoğlu, M., Hancı, F., Şengenç, E., Saltık, S., Kırkgöz, H. H., Karakayalı, B., Türkdoğan, D., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3122
Safety And Efficacy of Lacosamide and Levetiracetam in Children –A Cohort Study
Jebastine, M. I. (2024) · African Journal of Biomedical Research · doi:10.53555/ajbr.v27i3s.2077
YiJun, X., Li, Y., Liu, H., Shao, Y., Zhang, B., Jiang, Q., Jiang, C., Wu, J., & Wu, H. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4971468
Insights from a single-center study: Cessation of Anti-seizure Medication in Neonatal seizures
Çetin, İ. D., Özdil, M., Çağlar, A., & Çetin, O. (2024) · Eastern Journal Of Medicine · doi:10.5505/ejm.2024.49225
Arai, Y., Okanishi, T., Masumoto, T., Noma, H., Maegaki, Y., & on behalf of the Japan Environment and Children’s Study Group (2024) · PLoS ONE · doi:10.1371/journal.pone.0311666
Antecedentes perinatales de pacientes menores de 6 años con diagnóstico de epilepsia
Fariña, M., Toñánez, C. F., Cardozo, M. A. D., & Mesquita, M. N. (2024) · Pediatría (Asunción) · doi:10.31698/ped.51032024006
Unique Surgical Challenges in Early Life Epilepsy
Perry, M. S., & Hansen, D. R. (2025) · Seminars in Neurology · doi:10.1055/a-2519-2923
[Efficacy and safety of perampanel add-on therapy in children with epilepsy of genetic etiology].
Yi, J.-Q., & Sun, D. (2025) · PubMed · doi:10.7499/j.issn.1008-8830.2409069
Chan, S.-Y. C., Warnes, P., Warsame, M., & Atan, D. (2025) · Journal of Pediatric Ophthalmology & Strabismus · doi:10.3928/01913913-20250103-01
Effect of sex on neuropsychiatric comorbidities in childhood epilepsy
Krant, N., Krueger, C. D., Homick, A. C. L., Tarrant, C. A., & Holmes, G. L. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110328
Lugo, J. N., Douglas, L. A., Reinhart, J. M., Blandin, K. J., Santana‐Coelho, D., & Lugo, J. N. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110466
Provoked Neonatal Seizures and Neonatal Onset Epilepsy
Shellhaas, R. A., & Glass, H. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00027-5
Endovascular Embolization for Refractory Pediatric Epilepsy
Srinivasan, E. S., Robinson, S., & Xu, R. (2025) · World Neurosurgery · doi:10.1016/j.wneu.2025.124405
de Oliveira, C. A., Iorio, E. L., & Espíndola, F. S. (2025) · Pediatric Reports · doi:10.3390/pediatric17050092
“Common ASD-associated comorbidities include intellectual disability [2], gastrointestinal disturbances [3], sleep abnormalities, and epilepsy [4], all of which impact quality of life [5].”
Makhado, T. G., Munyadziwa, M., Makhado, L., & Cooley-Strickland, M. (2025) · F1000Research · doi:10.12688/f1000research.169377.1
The utility of CNV analysis in identifying the molecular etiology of pediatric epilepsy patients
Zhang, S., Wang, X., Meng, J., Li, J., Dong, Y., Li, D., Shu, J., & Cai, C. (2025) · Pediatric Research · doi:10.1038/s41390-025-04427-w
Pediatric Resident, U. L. S. C., & Madrid, N. Y. (2024) · Journal of Artificial Intelligence & Robotics · doi:10.52768/3067-7947/1011
Va, K., Гейбатовна, Г. Л., & Vlasov, P. N. (2025) · Medical alphabet · doi:10.33667/2078-5631-2025-21-27-33
Chinarev, V. А., & Малинина, Е. В. (2025) · Medical alphabet · doi:10.33667/2078-5631-2025-21-33-38
Dung, N. T. K., Hùng, C. V., & Hương, Đ. T. (2025) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v195i10.3983
Neonatal developmental and epileptic encephalopathies. English version
Datta, A. (2025) · Clinical Epileptology · doi:10.1007/s10309-025-00805-w
Gupta, Y., Rakholia, R., Agarwal, P., & Kumar, A. (2025) · Asian Journal of Medical Sciences · doi:10.71152/ajms.v16i12.4865
Hu, D. K.-Y. (2023) · eScholarship (California Digital Library)
Biagini, G., Vinceti, M., & Barco, T. L. (2023) · IRIS UNIMORE (University of Modena and Reggio Emilia)
Kolbjer, S. (2023) · Open Archive (Karolinska Institutet)
Beesley, R. E. (2025) · Lancaster EPrints (Lancaster University) · doi:10.17635/lancaster/thesis/2973
Enhancing cognitive outcomes in paediatric epilepsy: a feasibility study and systematic review
Aitken, R. (2025) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.85521
Liu, J., Du, J., Dai, Y., Huang, H., Chen, D., Hu, H., Tang, L. V., Zhou, W., Yang, Z., & Mao, Y. (2025) · Critical Public Health · doi:10.1080/09581596.2025.2605786
Damkjær, M., Morris, J. K., Ballardini, E., Barrachina‐Bonet, L., Cavero-Carbonell, C., Coi, A., Gissler, M., Given, J. E., Heino, A., Jordan, S. E., et al. (2026) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2026.01.003
Suryawanshi, V. R., Srivastava, K., Priya, A., Sarangi, B. U., & Raut, A. (2026) · Epilepsy Research · doi:10.1016/j.eplepsyres.2026.107738
Analysis of treatment outcome variations in infantile epileptic spasms syndrome
Gong, X., Gan, J., Wang, X., Chen, J., Rao, X., Wang, J., Shen, Y., & Zhang, J. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1749636
Corticosteroids as Treatment in Children‘s Epilepsy
Tamulionytė, G. (2024) · Lithuanian University of Health Sciences
Serebral Palsiye Bütüncül Yaklaşım
Türkyılmaz, N. N., Özdemir, G., Unsal, N., Aksoy, B., Bolacali, E. T., Topcuoğlu, H. K. K., Olgun, P. S., İNAN, P., Önder, E., Yaran, M., et al. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.4030
Wheless, J. W., Shahid, A. M., & Vidaurre, J. A. (2026) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2026.03.019
Kết quả điều trị hội chứng động kinh cơn co thắt trẻ nhỏ tại Bệnh viện Nhi Trung ương
Dung, N. T. P., Duyên, V. T., Hùng, C. V., & Hương, Đ. T. (2026) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v200i3.4782
KCC2 into the spotlight : from physiology to pathology
Hamze, M. (2023) · theses.fr (ABES) · doi:10.70675/25267775zf815z4920zb957zd68879fc263e
Mangano, G. D., Pasquale, G. D., Comisi, F. F., Angileri, V. M., Antona, V., Duca, V., Salpietro, V., & Mangano, G. R. (2026) · Seizure · doi:10.1016/j.seizure.2026.04.019
Wurzel, K. K. (2026) · e-Publications@Marquette (Marquette University)
Jiang, C., Ju, K., You, Y., Zhao, Y., Wang, J., Guo, C., & Cui, Z. (2026) · Epileptic Disorders · doi:10.1002/epd2.70264
Mechanisms of presynaptic dysfunction in rodent models of epilepsy
Hogg, J. (2026) · ERA · doi:10.7488/era/7202
Особенности использования противосудорожной терапии у детей раннего возраста
Лебедев, А. В., & Кащевская, В. М. (2026) · International journal of medicine and psychology. · doi:10.58224/2658-3313-2026-9-3-12-21
Clınıcal and aetıologıcal spectrum of chıldhood epılepsy accordıng to the ILAE 2017 classıfıcatıon
Özeç, B., Yılmaz, D., & Kurt, A. N. Ç. (2026) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2026.111100
Guo, W., Song, D., Cheng, K., Wang, C., Wang, Y., Yang, X., Lin, Y., Jiang, X., Liu, X., & Li, L. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1841342
Accorinti, I., Neri, M., Celardo, G. M., Papoff, F. M. A., Bonezzi, L., Biagioni, T., Orsi, M. C., Bartolini, E., & Battini, R. (2026) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2026.111116
Expanding the phenotypic spectrum of FGF12-epilepsy—does prompt precision therapy affect outcomes?
Arkush, L., Karandasheva, K., Ouellet, F., D’Gama, A. M., Sheidley, B. R., Liang, N. S. Y., Chau, V., Costain, G., Smith, L. A., Alwis, A., et al. (2026) · npj Genomic Medicine · doi:10.1038/s41525-026-00581-0
“Fig.2cdemonstratesamigratingseizurepatternseeninPatient2atage 4monthswithseizurecessationonlidocaineinjection.”
InfluentialEEG in the diagnosis and management of early childhood epilepsies
Zaddach, M., Borggraefe, I., Craiu, D., & Eisermann, M. (2026) · Clinical Epileptology · doi:10.1007/s10309-026-00850-z
Kılıç, K. M., & Aydin, H. (2026) · Brain and Development · doi:10.1016/j.braindev.2026.104557
Epilepsia relacionada ao gene KCNQ2: uma análise clínica de fenótipos distintos
Rodrigues, F. D. S. R., Nuayed, A. C. M., Pereira, M. K. D. O., Machado, A. L. M., Rodrigues, J. F. R., & Freitas, J. P. (2026) · Revista Neurociências · doi:10.34024/rnc.2026.v34.20824
Ueda, T., Suzuki, H., Mitsuhashi, T., Nishioka, K., Nomura, K., Akiba, T., Matsuda, S., Igarashi, A., Sugano, H., Urabe, Y., et al. (2026) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2026.100875
Antiseizure Medication Trials Before Referral in Pediatric Patients Undergoing Epilepsy Surgery
Zheng, V., Gaily, E. K., Karppinen, A., Koroknay-Pál, P., Lehtinen, H., & Metsähonkala, E. (2026) · Neurosurgery · doi:10.1227/neu.0000000000004126
Shrock, C. L., Savage, M. C., Sham, L., Cortina, C., Gray, K. P., Lee, I., Triki, C., French, J. A., Cross, J. H., Devinsky, O., et al. (2026) · Epilepsia Open · doi:10.1002/epi4.70292
Late-onset epileptic spasms: presentation, aetiology and outcome
Dal, S., Macdonald‐Laurs, E., Mandelstam, S. A., Kerr, R., Chan, E. K., Santamaria, K., Maixner, R., Wray, A. C., D’Arcy, C. E., Kokulan, R., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag224
Samsuddin, S. W., Bazo‐Alvarez, J. C., Schartau, P., & Petersen, I. (2026) · PLoS ONE · doi:10.1371/journal.pone.0351169
“However, the association between epilepsy and social deprivation is less clear [38].”
Einführung: Frühkindliche Epilepsien und epileptische Syndrome
Bertsche, A., & Neininger, M. P. (2026) · Clinical Epileptology · doi:10.1007/s10309-026-00855-8
The Bright Side of the Spectrum: Self‐Limited Infantile Epilepsy‐Related SCN8A Gof Variant
Keskin, F., Günay, Ç., Doğan, G., Baydan, F., & Uzan, G. S. (2026) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.70154
Chen, H., Zhong, J., Chen, Y., Wu, H., Wang, R., Yi, Z., & Zeng, X. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1848952
“The estimated incidence of IESS is 30 per 100,000 live births; some studies have suggested a higher incidence in high-latitude regions (Sweden, Finland, Denmark) (3– 6).”
Cieślak, M., Gątarek, P., Safiński, P., Przysło, Ł., & Kałużna‐Czaplińska, J. (2026) · Nutrients · doi:10.3390/nu18142347
“Furthermore, in the first 3 years of life, 35% of children develop drug-resistant epilepsy [2].”
Vigabatrin therapy for infantile epileptic spasms syndrome with periventricular leukomalacia
Oba, A., Matsuura, R., Horita, H., Daida, A., Hirata, Y., Koichihara, R., Hamano, S.-I., Kanbe, T., & Kikuchi, K. (2026) · Brain and Development · doi:10.1016/j.braindev.2026.104574
Zhou, X., Yuan, Y., Wu, Q., Xv, L., & Liu, C. (2026) · Biomedical Reports · doi:10.3892/br.2026.2224
Yaman, B., Kürekçi, F., Akbaş, S., Oney, C., Kılıç, M. A., Genç, H. M., Aslanger, A. D., & Yıldız, E. P. (2026) · Epileptic Disorders · doi:10.1002/epd2.70356
PANORAMA EPIDEMIOLÓGICO DA EPILEPSIA PEDIÁTRICA NA REGIÃO NORDESTE, ENTRE 2016 E 2025
Vieira, A. S. D. S., Ramos, F. L. S. B., Alves, M. D. A., Filho, L. F. D., Malta, M. V. D. S., & Costa, A. F. P. (2026) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v12i8.29221
Children and young people with chronic health conditions in the Midland region (2022)
Duncanson, M., Adams, J., Tustin, K., van Asten, H., Roy, M., Oben, G., McAnally, H. M., & Wicken, A. (2023) · Otago University Research Archive (University of Otago)
Children and young people with chronic health conditions in MidCentral and Whanganui (2022)
Duncanson, M., Adams, J., Tustin, K., van Asten, H., Roy, M., Oben, G., McAnally, H. M., & Wicken, A. (2023) · Otago University Research Archive (University of Otago)
Park, S. J., Tan, J. M. M., Peng, X., Wong, P. Y. W., Tay, K. S. S., Koe, A. S. H., Tye, J. S. N., Chai, J. Y. H., Koh, P. X., Tan, Y., et al. (2026) · Epilepsia Open · doi:10.1002/epi4.70327
Impactos da epilepsia e suas comorbidades nas alterações de linguagem em escolares: estudos de casos
da Silva, T. E. M., Azevedo, A. I. D. L., Avelino, E. M. R., & Azoni, C. A. S. (2026) · Revista CEFAC · doi:10.1590/1982-0216/20262824925
Kayar, Ç. D., Akbaş, S., Kürekçi, F., Yaman, B., Kılıç, M. A., Genç, H. M., & Yıldız, E. P. (2026) · Epileptic Disorders · doi:10.1002/epd2.70382
Aledo‐Serrano, Á., Carbó, A. V., Alguacil, E. G., García-Peñas, J. J., Jamardo, A. S., Laín, G. A., Ibáñez‐Micó, S., Martínez, H. A., Espartosa, R. B., Rekarte-García, S., et al. (2026) · Epilepsia · doi:10.1002/epi.70460
Carapancea, E., Semal, B., Merci, N., Pugliano, R., Sands, T. T., Cilio, M. R., & Aeby, A. (2026) · Seizure · doi:10.1016/j.seizure.2026.08.028
Şeref, İ. Ş., Öztürk, Z., Özbaş, C., Serdaroğlu, E., Arhan, E., Hırfanoğlu, T., & Demir, E. (2026) · Brain and Development · doi:10.1016/j.braindev.2026.104587
Herini, E. S., Triono, A., Iskandar, K., Nugrahanto, A. P., Damroni, R. A., Mooiindie, K. H., & Timoti, J. (2026) · Neurogenetics · doi:10.1007/s10048-026-00932-0
“While the underlying etiology of epilepsy remains unclear in most cases, genetic factors are believed to play a significant role in both disease progression and treatment resistance [ 3 , 4].”
Gulisano, C., Pepe, A., Amadori, E., Caruggi, S., Caratozzolo, D., Nobili, L., Striano, P., Ramenghi, L. A., & Calandrino, A. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1949800
“Although phenobarbital remains the recommended first-line antiseizure medication and phenytoin or levetiracetam are commonly used as second-line therapies, a substantial proportion of neonates continue to experience seizures despite escalating treatment (11).”
García-García, V. A., Ramírez‐Sánchez, M. V., García-Romero, R. C., Jasso-García, I., Garcia-Martínez, D., Tavares-Ortega, A., Gonzalez-Gonzalez, A. M., Estrada-Hernández, R. C., Sánchez-Miranda, M. F., Castillo‐Cardiel, G., et al. (2026) · Chinese Neurosurgical Journal · doi:10.1186/s41016-026-00446-6
“The overall global prevalence of epilepsy has been reported as 7.60 per 1,000 inhabitants [1].”
InfluentialClobazam in pediatric drug-resistant epilepsy: from pharmacology to clinical practice
Wan, J., Yu, Y., Liu, X., Zeng, M., Xie, X., Deng, T., Zhao, M., & Wang, X. (2026) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-026-04181-w
Liu, J., Chen, J., Lin, H., Wang, D., Chen, N., Lin, D., Li, Y., Zhang, C., Liu, S., Shen, K., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107604
Kamgang, S., & Myers, K. A. (2026) · Epileptic Disorders · doi:10.1002/epd2.70409
Digital twins in neuroscience: A narrative review of technical challenges for child neurology
Canepa, M. E., Villano, G., Ramenghi, L. A., di Pianella, A. V., & Striano, P. (2026) · Advanced technology in neuroscience . · doi:10.4103/atn.atn-d-26-00025
Su, Q., Yin, Y., Cheng, H., Yan, Y., Jin, J., Shao, Y., Sheng, J., Tao, A., Ruan, G., Cui, L., et al. (2026) · Translational Pediatrics · doi:10.21037/tp-2026-0593
“Epilepsy represents one of the most frequently encountered neurological conditions in the pediatric population, with approximately 239 new cases diagnosed annually per 100,000 children (1).”
Li, J., Fan, W., Liu, N., Zhang, S., Wang, P., Gu, C., & Shu, J. (2026) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70305
“The focus of this study is on developmental delay and intermittent epilepsy in children, significantly affecting patients' daily lives and development and imposing a huge economic burden on families and society (Albaradie et al. 2021; Hiraide et al. 2021; Symonds et al. 2021).”
Clinicoetiological profile of epileptic syndromes in infants and early childhood
El-Daly, E. E.-D. M. H., Aladawy, M. A.-A., & Abdelrahman, A. A. H. (2026) · Al-Azhar Assiut Medical Journal · doi:10.4103/azmj.azmj_19_26
Bilal, M., Noor, A., Khan, M. T. H., Kayani, J. A., Hamdani, M., & Mufti, M. (2025) · Annals of Punjab Medical College
Butnariu, L. I., Grigore, E., Schreiner, T. G., Băgiag, A. M., Popa, S., & Grigore, I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198878
“Monogenic etiologies explain about 20–40% of recruited cases with early-onset epilepsies in different studies [13–15], while among adults with epilepsy and co-occurring neurodevelopmental disorders, the diagnostic yield ranges from 23% to 50% [16].”
Keenan, N. (2024) · Otago University Research Archive (University of Otago)
Metadata
- Authors
- Symonds, J. D., Elliott, K. S., Shetty, J., Armstrong, M., Brunklaus, A., Cutcutache, I., Diver, L. A., Dorris, L., Gardiner, S., Jollands, A., Joss, S., Kirkpatrick, M., McLellan, A., MacLeod, S., O’Regan, M., Page, M., Pilley, E., Pilz, D. T., Stephen, E., Stewart, K., Ashrafian, H., Knight, J. C., & Zuberi, S. M.
- Affiliations
- Royal Hospital for Children (GB)
- Centre for Human Genetics (GB)
- UCB Pharma (Belgium) (BE)
- UCB Pharma (United Kingdom) (GB)
- Queen Elizabeth University Hospital (GB)
- NHS Tayside (GB)
- University of Dundee (GB)
- Royal Aberdeen Children's Hospital (GB)
- John Radcliffe Hospital (GB)
- Corresponding author
- Zuberi, Sameer M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-09-01
- Volume
- 144
- Issue
- 9
- Pages
- 2879-2891
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC8557326
- OpenAlex
- W3168961767
- Cited by
- 269
- References
- 44
- Citations by year
- 2026: 66 · 2025: 72 · 2024: 64 · 2023: 49 · 2022: 17
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
- Funders
- Dravet Syndrome UK
- Epilepsy Research UK
- Glasgow Children’s Hospital Charity
- UCB Pharma
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- early childhood epilepsy, epilepsy incidence, socioeconomic deprivation, epilepsy etiology, drug-resistant epilepsy, global developmental delay, epilepsy syndromes, genetic epilepsy, whole genome sequencing, mark-recapture, epilepsy classification, Scotland, children under 3 years, gene therapy, precision medicine, neuroimaging, prospective cohort
- MeSH terms
- Drug Resistant Epilepsy, Child, Preschool, Epilepsy, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Prospective Studies, Retrospective Studies, Scotland, Socioeconomic Factors, Cohort Studies, Causality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.